Close

Clinical Trials

Eli Lilly and Company in Collaboration with Strateos Launch Remote-Controlled Robotic Cloud Lab

Eli Lilly and Company and Strateos, Inc. unveiled a new robotic laboratory in San Diego, California designed to accelerate the drug discovery process. The Lilly Life Sciences Studio lab was conceptualized and designed by Lilly as part of a...

Moderna Announces Additional Positive Phase 1 Data from CMV Vaccine and First Participant Dosed in Phase 2 Study

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced positive seven-month interim safety and immunogenicity data after the third and final vaccination in...

Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use

Signant Health announced a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome Assessment (eCOA) platform, to Propeller Health’s digital health platform for asthma and COPD (chronic obstructive pulmonary disease). The partnership will help drive patient adherence to inhaled medications...

ideaPoint Partners with SAS to Provide Leading Data Sharing Solution Through ClinicalStudyDataRequest.com

Anaqua’s ideaPoint, a leading provider of innovation management solutions, has announced a partnership with SAS, the world leader in analytics. The partnership will provide to pharmaceutical companies and academic researchers the most robust clinical trial data sharing solution, with...

Clariant has agreed to sell its Masterbatches business for approx. USD 1.6 billion

Clariant, a focused and innovative specialty chemical company, has agreed to sell its entire Masterbatches business to PolyOne. The transaction values the Masterbatches business at USD 1,560 million, representing c. 12.2 times the last twelve months reported EBITDA (ending...

Symbiosis invests $1.5 million in UK facility expansion

Stirling, UK – Fast-growing specialist sterile manufacturing and Contract Manufacturing Organisation (CMO) Symbiosis Pharmaceutical Services (Symbiosis), has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%. In the last 12 months Symbiosis has invested over £1.5m ($1.9m) in...

Janssen to Acquire Investigational Bermekimab from XBiotech

Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc. Bermekimab is an anti-IL-1alpha monoclonal antibody (mAb) in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read